Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorogenic acid in advanced cancer
NCT02136342Phase 1Terminated
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- May 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of chlorogenic acid in cancer, sponsored by Chinese Academy of Medical Sciences. Primary endpoint: Number of adverse events at 60 days. Started May 2014; status: terminated.
02
Drugs
chlorogenic acid
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02136342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136342.